UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001267
Receipt number R000001381
Scientific Title Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer
Date of disclosure of the study information 2008/07/25
Last modified on 2012/07/25 09:31:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer

Acronym

Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer

Scientific Title

Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer

Scientific Title:Acronym

Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer

Region

Japan


Condition

Condition

gallbladder cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Hematology and clinical oncology Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

efficacy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

efficacy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

anti-cancer drug

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

The study is designed to enroll patients with nonresectable, pathologically proven, gallbladder cancer. Other eligibility criteria includes no prior therapy, performance status of 0-2.
Written informed consent is required from all patients.

Key exclusion criteria

The exclusion criteria are as follows: active infection.
pregnant or lactating women, women of childbearging age.
the patient inappropriate for entry onto this study in the judgment of the investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiki Hirooka

Organization

Nagoya University Hospital

Division name

Department of Endoscopy

Zip code


Address

65,Tsuruma-Cho,Showa-Ku,Nagoya City

TEL

052-744-2602

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yoshiki Hirooka

Organization

Nagoya University Hospital

Division name

Department of Endoscopy

Zip code


Address


TEL

052-744-2602

Homepage URL


Email



Sponsor or person

Institute

Nagoya University Hospital

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 02 Month 18 Day

Date of IRB


Anticipated trial start date

2008 Year 04 Month 01 Day

Last follow-up date

2012 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2012 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 07 Month 25 Day

Last modified on

2012 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001381


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name